Q3 delivered 7.8% sales growth and a 10.6% adjusted operating margin, driven by pricing and productivity gains. Volume growth returned across all customer types, with vending and implant solutions up mid-teens. Q4 guidance anticipates continued sales and margin strength.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.